KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2025)

Ginkgo Bioworks Holdings' Treasury Shares history spans 7 years, with the latest figure at $4.4 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 32.45% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $4.4 million, up 32.45%, while the annual FY2025 figure was $4.4 million, 32.45% up from the prior year.
  • Treasury Shares reached $4.4 million in Q4 2025 per DNA's latest filing, up from $1.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $238.7 million in Q1 2024 to a low of $241754.0 in Q3 2021.
  • Average Treasury Shares over 5 years is $64.5 million, with a median of $22.4 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: skyrocketed 89110.27% in 2022, then tumbled 99.67% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $27.9 million in 2021, then soared by 382.49% to $134.4 million in 2022, then crashed by 97.17% to $3.8 million in 2023, then dropped by 12.55% to $3.3 million in 2024, then surged by 32.45% to $4.4 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Treasury Shares are $4.4 million (Q4 2025), $1.9 million (Q3 2025), and $5.0 million (Q2 2025).